<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="443.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <section>
    <h1 class="tit">アクテムラは投与初期ではADD-ON群のほうがDAS28寛解率が有意に高いが、52週では両群で有意差はなくなる（SURPRISE Study）</h1>
  </section>

  <section>
    <div class="img"><img src="img/348-1.png" alt=""></div>
    <p class="txt">投与初期ではADD-ON群のほうがDAS28寛解率が有意に高いが、52週では両群で有意がない</p>
    <div class="greenbox"><p><strong>→最初はMTXを併用し疾患コンロトール良好な場合はMTXを中止する治療戦略が可能</strong></p></div>
    <p class="txt sml right"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=E47020&skey=4b04e565-88bb-4caf-90bc-0e7881da39da">Kaneko Y, et al. Ann Rheum Dis. 2016 Jan 5.</a></p>
  </section>

</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="443.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
